查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566887

羊膜產品市場：按產品、應用和最終用戶分類：2024-2033 年全球機會分析和產業預測

Amniotic Product Market By Product , By Application By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

羊膜產品市場

2023年羊膜產品市值為9億美元，預計2024年至2033年複合年成長率為6.9%，到2033年將達18億美元。

羊膜產品，包括羊膜和胎盤液，由於含有細胞激素、生長因子和細胞外基質成分，是再生醫學的重要組成部分。羊膜產品可用於促進組織修復、減少發炎和預防疤痕，並以移植物、貼片、注射和局部溶液的形式提供。羊膜產品的作用涉及輸送生物活性分子，促進細胞遷移、增殖和分化，從而促進癒合和減少發炎。

組織工程的進步促進了維持羊膜產品生物活性的創新技術的發展。這些技術創新是羊膜產品市場的關鍵促進因素。此外，人們對幹細胞治療和再生醫學的日益偏好正在推動促進組織再生和修復的羊膜產品的採用。靜電紡絲和積層製造技術的使用正在推動羊膜產品在組織工程中的使用擴大。這些技術有助於開發新型多層複合羊膜，可用於神經再生等多種臨床應用。

羊水屬於 FDA 公共衛生服務法第 351 條的管轄範圍。然而，由於遵守政府機構和美國食品和藥物協會（FDA）等聯邦機構實施的法規的途徑昂貴且耗時，羊水產品市場發展狀況非常具有挑戰性。因此，羊水產品的使用和銷售需要獲得核准的生技藥品許可證申請。如果沒有執照，您將受到嚴厲的處罰和處罰。

分部審查

羊膜產品市場分為產品、應用、最終用戶和地區。從產品角度來看，市場分為冷凍羊膜和冷凍乾燥羊膜。依用途分為外科傷口、眼科、整形外科等。依最終使用者分為醫院、門診手術中心、專科診所、研究中心和實驗室。從區域來看，分析包括北美、歐洲、亞太地區和拉丁美洲地區。

主要發現

副產品中，冷凍羊膜佔有較高的市場佔有率。

從應用來看，外科傷口領域佔有很大佔有率。

從最終用戶來看，醫院部門佔有很高的佔有率。

按地區分類，北美在羊膜產品市場中收益最高。

可以使用此報告進行客製化（需要額外費用和時間表）

  • 監管指引
  • 根據客戶興趣新增其他公司簡介
  • 歷史市場資料
  • 導入/匯出分析/資料
  • 贖回場景

目錄

第1章 簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章 人造絲產品市場：依產品

  • 市場概況
  • 冷凍保存羊膜
  • 凍乾羊膜

第5章羊水產品市場：依應用分類

  • 市場概況
  • 手術傷口
  • 眼科
  • 整形外科
  • 其他

第6章 Amiotech 產品市場：依最終用戶分類

  • 市場概況
  • 醫院
  • 門診手術中心
  • 專科診所
  • 研究中心研究所

第7章羊膜產品市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國羊膜產品市場
    • 加拿大羊膜產品市場
    • 墨西哥羊膜產品市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國羊膜產品市場
    • 德國羊膜產品市場
    • 義大利羊膜產品市場
    • 西班牙羊膜產品市場
    • 英國羊膜產品市場
    • 其他歐洲國家羊膜產品市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國羊膜製品市場
    • 日本羊膜產品市場
    • 印度羊膜產品市場
    • 韓國羊膜產品市場
    • 澳洲羊膜產品市場
    • 其他亞太羊水產品市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西羊膜產品市場
    • 南非羊膜產品市場
    • 沙烏地阿拉伯羊膜產品市場
    • 其他拉丁美洲/中東/非洲羊膜產品市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • Allosure, Inc.
  • Amnio Technology, LLC
  • Applied Biologics LLC
  • FzioMed, Inc.
  • Human Regenerative Technologies, LLC
  • Integra Lifesciences Holdings Corporation
  • Corza Ophthalmology
  • MiMedx Group, Inc.
  • Skye Biologics Inc.
  • Tissue-Tech, Inc.
簡介目錄
Product Code: A216556

Amniotic Product Market

The amniotic product market was valued at $0.9 billion in 2023 and is projected to reach $1.8 billion by 2033, growing at a CAGR of 6.9% from 2024 to 2033.

Amniotic product, including amniotic membrane and fluid of the placenta, is an essential component of regenerative medicine due to the presence of cytokines, growth factors, and extracellular matrix components. The products are useful in the promotion of tissue repair, reduction of inflammation, & scar prevention and are available in the form of grafts, patches, injections, and topical solutions. The working of amniotic products includes the delivery of bioactive molecules to enhance cellular migration, proliferation, and differentiation, which results in accelerated healing & reduced inflammation.

Advancements in tissue engineering have led to the development of innovative techniques for preserving the bioactivity of amniotic products. These innovations are a key driver of the amniotic product market. In addition, surge in preference for stem cell therapies and regenerative medicine is boosting the adoption of amniotic products, as they promote tissue regeneration and repair. To expand the usage of amniotic products in tissue engineering, the usage of electrospinning and additive manufacturing technologies is acquiring traction. These technologies help in the development of novel multilayer composite-based amniotic membranes which are utilized for several clinical applications such as nerve regeneration.

However, the development landscape for the amniotic product market is highly challenging due to the expensive and time-consuming pathway regarding compliance with the regulations imposed by the government or federal agencies such as the Food and Drug Association (FDA) in the U.S. Amniotic fluid falls under Section 351 of the Public Health Service Act by the FDA. Hence, usage and marketing of the amniotic products require an approved Biologics License Application. The case of non-availability of the license leads to heavy penalties and punishment.

Segment Review

The amniotic product market is segmented into product, application, end user, and region. On the basis of product, the market is bifurcated into cryopreserved amniotic and lyophilization amniotic. As per application, it is classified into surgical wounds, ophthalmology, orthopedic, and others. By end user, it is divided into hospitals, ambulatory surgical centers, specialized clinics, and research centers & laboratory. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the cryopreserved amniotic segment accounts for a high market share.

As per application, the surgical wounds segment acquires a high stake in the market.

By end user, the hospitals segment holds a high share in the market.

Region wise, North America generates the highest revenue in the amniotic product market.

Competition Analysis

The leading players operating in the global amniotic product market include Allosure, Inc., Amnio Technology, LLC, applied biologics llc, FzioMed, Inc., Human Regenerative Technologies, LLC, Integra Lifesciences Holdings Corporation, Corza Ophthalmology, MiMedx Group, Inc., Skye Biologics Inc., and Tissue-Tech, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Historic market data
  • Import Export Analysis/Data
  • Reimbursement Scenario

Key Market Segments

By Product

  • Cryopreserved Amniotic
  • Lyophilization Amniotic

By Application

  • Surgical Wounds
  • Ophthalmology
  • Orthopedic
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Research Centers Laboratory

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Allosure, Inc.
    • Amnio Technology, LLC
    • applied biologics llc
    • FzioMed, Inc.
    • Human Regenerative Technologies, LLC
    • Integra Lifesciences Holdings Corporation
    • Corza Ophthalmology
    • MiMedx Group, Inc.
    • Skye Biologics Inc.
    • Tissue-Tech, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: AMNIOTIC PRODUCT MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Cryopreserved Amniotic
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Lyophilization Amniotic
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: AMNIOTIC PRODUCT MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Surgical Wounds
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Ophthalmology
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Orthopedic
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: AMNIOTIC PRODUCT MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Ambulatory Surgical Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Specialized Clinics
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Research Centers Laboratory
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: AMNIOTIC PRODUCT MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Amniotic Product Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Amniotic Product Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Amniotic Product Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Amniotic Product Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Amniotic Product Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Amniotic Product Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Amniotic Product Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Amniotic Product Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Amniotic Product Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Amniotic Product Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Amniotic Product Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Amniotic Product Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Amniotic Product Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Amniotic Product Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Amniotic Product Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Amniotic Product Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Amniotic Product Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Amniotic Product Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Amniotic Product Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Allosure, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Amnio Technology, LLC
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Applied Biologics LLC
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. FzioMed, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Human Regenerative Technologies, LLC
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Integra Lifesciences Holdings Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Corza Ophthalmology
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. MiMedx Group, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Skye Biologics Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Tissue-Tech, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments